APYX

Apyx Medical Corporation · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-10

Figures on this page computed 2026-11-08 12:40 UTC

Last close

3.06USD

Market data, 2026-11-05

Except where said otherwise: 10-K for 2025, filed 2026-03-10

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-10
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-06
The filing itself
-21.2%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
The filing itself
-17.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
The filing itself
2.71Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-06
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.42 against 0.58 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.56x

1.45x

0.69x

2.54x

0.59x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-05

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-10

Sales1.56x
Its own average over 10 years, 33.8M.
Profit1.45x
Its own average over 10 years, -7.7M.
Free cash flow0.69x
Its own average over 10 years, -13.1M.
Debt2.54x
Its own average over 8 years, 15.5M.
Price0.59x
Its own average over 8 years, 5. Market data, 2026-11-05

Debt is furthest from its own average, at 2.54 times.

Sales is 1.56 times its own 10-year average; Profit is 1.45 times its own 10-year average; Free cash flow is 0.69 times its own 10-year average; Debt is 2.54 times its own 8-year average; Price is 0.59 times its own 8-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-10

Sales against its own 10-year average1.56
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
The filing itself
Profit against its own 10-year average1.45
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
The filing itself
Free cash flow against its own 10-year average0.69
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
The filing itself
Debt against its own 8-year average2.54
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437749-26-007471
Reported in
USD
The filing itself
Price against its own 8-year average0.59Market data, 2026-11-05
Source
market
Taken on
2026-11-05
Reported in
USD